Libytec Q10Stat 60.caps - is a unique product with double protective action

The modern way of life has increased the risk factors for the occurrence of cardiovascular diseases and liver diseases.

Cardiovascular disease is the leading cause of death worldwide. In Greece more than 360 people per 100,000 die every year from them. Statins are one of the most established treatments for the prevention and treatment of atherosclerotic cardiovascular diseases. However, their use has been associated with the occurrence of side effects such as myopathy and the risk of liver damage.
The efficient functioning of the liver is essential for the proper functioning of the gastrointestinal tract but also for general health. Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and is associated with an increased risk of atherosclerotic cardiovascular disease, regardless of the presence of diabetes, hypertension and obesity.

Libytec Pharmaceuticals has developed Q10Stat an innovative combination containing CoQ10, selenium, choline, artichoke and thistle extract and vitamins C, B1, B6, and B12.

The primary function of CoQ10 is its involvement in intracellular energy production. Statins, in addition to lowering the synthesis of cholesterol, also reduce the synthesis of other substances such as CoQ10 and selenium proteins.

Despite this reduction, tissue concentrations of CoQ10 decrease with age and its nutritional intake is usually insufficient in pathological conditions.

In clinical practice, the addition of CoQ10 to statin therapy effectively reduces muscle symptoms, while its addition to conventional therapy in patients with chronic heart failure:

improves symptoms
significantly reduces the main adverse cardiovascular events

Another component of Q10Stat is choline, an essential molecule for the synthesis of certain neurotransmitters, cell membranes and lipoproteins. The liver is the main organ responsible for its metabolism. Choline contributes to:

in the normal metabolism of homocysteine
in normal lipid metabolism
in maintaining normal liver function

Choline deficiency can:

cause muscle damage and abnormal fat deposition in the liver
lead to the development of NAFLD

The synergistic effects of Q10stat are enhanced by the presence of selenium, artichoke and thistle extracts which have a hepatoprotective effect and a beneficial effect on non-alcoholic fatty liver disease, as well as vitamins C, B1, B6 & B12 which contribute to homocysteine ​​metabolism.

There is a significant interdependence between CoQ10 and selenium. Selenium deficiency can prevent cells from achieving optimal CoQ10 concentrations, and adequate CoQ10 concentrations must be available for cells to benefit from optimal selenium function.

Artichoke extracts affect lipid metabolism by reducing the endogenous production of cholesterol and triglycerides and enhancing their excretion or redistribution. They also increase bile production by increasing the amount of bile acids and cholesterol excreted in the bile.

The active ingredients of thistle can also have beneficial effects on non-alcoholic fatty liver disease and are able to neutralize the hepatotoxicity of many substances (ethanol, paracetamol, mushroom poisoning) because they have action:

as antioxidants by regulating intracellular glutathione content
as permeability regulators that prevent hepatotoxic agents from entering hepatocytes
as stimulants of liver regeneration
as inhibitors of hepatocyte transformation into myofibroblasts

Vitamin C is one of the most powerful antioxidants and a free radical scavenger in biological systems. Diseases such as cardiovascular disorders are associated with inadequate concentrations. Therefore, an optimal intake of vitamin C can help protect against atherosclerosis and its clinical consequences.

Vitamin B1 contributes to the normal functioning of the heart. Vitamins B6 and B12 help normal homocysteine ​​metabolism and reduce fatigue and tiredness.

In short, Q10Stat is a unique product with dual protective action that can have a positive effect on:

arteriosclerosis
ischemic heart disease
chronic heart failure
hypertrophic cardiomyopathy
hypertension
statin-induced cardiomyopathy
non-alcoholic fatty liver disease

Administration of Q10Stat may:

Improves cardiac energy balance
Reduces symptoms in patients with heart failure
Reduces major adverse cardiovascular events
Treats and prevents muscle symptoms due to statins

It has a hepatoprotective effect
Helps regulate liver enzymes
It can be co-administered with standard treatments
Q10Stat is recommended for:

to those taking statins
in those suffering from cardiovascular diseases
for hepatoprotective action

60 caps.